{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:28:35Z","timestamp":1792819715373,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is a rare but potentially fatal event. In this systematic review, we searched PubMed and Embase for large TAVI studies and registries to identify the incidence, presentation, microbiology, risk factors, and outcomes of IE in this population. After application of the selection criteria and quality assessment, 8 studies representing 255,310 TAVR cases and 4218 cases of IE qualified for this review. IE following TAVI is uncommon with an incidence of 0.87 to 1.7 events per 100 person-years. Most events occur in the first year following valve implantation. <jats:italic toggle=\"yes\">Staphylococcus<\/jats:italic>, <jats:italic toggle=\"yes\">Enterococcus<\/jats:italic>, and <jats:italic toggle=\"yes\">Streptococcus<\/jats:italic> species are the most common pathogens. Risk factors include age, sex, concomitant comorbidities, and procedural factors. Outcomes are dismal, and surgical intervention is rare in this population.<\/jats:p>","DOI":"10.1097\/crd.0000000000000460","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T16:00:12Z","timestamp":1653321612000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Infective Endocarditis After Transcatheter Aortic Valve Implantation: A Systematic Review"],"prefix":"10.1097","volume":"31","author":[{"given":"Ahmed","family":"Hassanin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Afify","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, University of Louisville School of Medicine, Louisville, KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Zook","sequence":"additional","affiliation":[{"name":"Houston Methodist DeBakey Heart & Vascular Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jamacardio.2021.2534","article-title":"Guideline update on indications for transcatheter aortic valve implantation based on the 2020 American College of Cardiology\/American Heart Association Guidelines for management of valvular heart disease.","volume":"6","author":"Sundt","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R2-20250619","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT registry of transcatheter aortic valve replacement.","volume":"76","author":"Carroll","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250619","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/CIRCULATIONAHA.119.041399","article-title":"Prosthetic valve endocarditis after TAVR and SAVR: insights from the PARTNER trials.","volume":"140","author":"Summers","year":"2019","journal-title":"Circulation"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.2016.12347","article-title":"Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death.","volume":"316","author":"Regueiro","year":"2016","journal-title":"JAMA"},{"key":"R7-20250619","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.jacc.2020.04.044","article-title":"Infective endocarditis after transcatheter aortic valve replacement.","volume":"75","author":"Stortecky","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jcin.2020.05.012","article-title":"Incidence, predictors, and outcomes of endocarditis after transcatheter aortic valve replacement in the United States.","volume":"13","author":"Mentias","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.cmi.2020.01.036","article-title":"Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement.","volume":"26","author":"Fauchier","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.amjcard.2018.08.054","article-title":"Comparison of incidence, predictors, and outcomes of early infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement in the United States.","volume":"122","author":"Kolte","year":"2018","journal-title":"Am J Cardiol"},{"key":"R11-20250619","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/eurheartj\/ehz588","article-title":"Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.","volume":"40","author":"Bjursten","year":"2019","journal-title":"Eur Heart J"},{"key":"R12-20250619","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s12471-020-01420-2","article-title":"Incidence and outcome of prosthetic valve endocarditis after transcatheter aortic valve replacement in the Netherlands.","volume":"28","author":"Brouwer","year":"2020","journal-title":"Neth Heart J"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jhin.2018.05.014","article-title":"In-hospital infective endocarditis following transcatheter aortic valve replacement: a cross-sectional study of the National inpatient sample database in the USA.","volume":"100","author":"Yeo","year":"2018","journal-title":"J Hosp Infect"},{"key":"R14-20250619","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.jcin.2021.07.015","article-title":"Surgical explantation after TAVR failure: mid-term outcomes from the EXPLANT-TAVR international registry.","volume":"14","author":"Bapat","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"R15-20250619","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/CIRCULATIONAHA.114.014089","article-title":"Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry.","volume":"131","author":"Amat-Santos","year":"2015","journal-title":"Circulation"},{"key":"R16-20250619","doi-asserted-by":"crossref","first-page":"e00210","DOI":"10.1128\/mSphere.00210-17","article-title":"Comparison of the microbiota of older adults living in nursing homes and the community.","volume":"2","author":"Roghmann","year":"2017","journal-title":"mSphere"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"e017347","DOI":"10.1161\/JAHA.120.017347","article-title":"Infective endocarditis after surgical and transcatheter aortic valve replacement: a state of the art review.","volume":"9","author":"Alexis","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"e3750","DOI":"10.1093\/cid\/ciaa1941","article-title":"Temporal trends, characteristics, and outcomes of infective endocarditis after transcatheter aortic valve replacement.","volume":"73","author":"Del Val","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document.","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2013.01.092","article-title":"Positron emission tomography\/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion.","volume":"61","author":"Saby","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00330-012-2491-5","article-title":"ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis.","volume":"22","author":"Fagman","year":"2012","journal-title":"Eur Radiol"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM).","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines.","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease.","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1056\/NEJMoa1112843","article-title":"Early surgery versus conventional treatment for infective endocarditis.","volume":"366","author":"Kang","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:01:49Z","timestamp":1750348909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000460","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,23]]}}}